ATE538774T1 - Pharmazeutische formulierungen und verfahren zur behandlung von atemwegsinfektionen - Google Patents
Pharmazeutische formulierungen und verfahren zur behandlung von atemwegsinfektionenInfo
- Publication number
- ATE538774T1 ATE538774T1 AT10711127T AT10711127T ATE538774T1 AT E538774 T1 ATE538774 T1 AT E538774T1 AT 10711127 T AT10711127 T AT 10711127T AT 10711127 T AT10711127 T AT 10711127T AT E538774 T1 ATE538774 T1 AT E538774T1
- Authority
- AT
- Austria
- Prior art keywords
- methods
- treating
- pharmaceutical formulations
- mole
- pulmonary disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/734—Alginic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Otolaryngology (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16377209P | 2009-03-26 | 2009-03-26 | |
US16376709P | 2009-03-26 | 2009-03-26 | |
US16376309P | 2009-03-26 | 2009-03-26 | |
US25576409P | 2009-10-28 | 2009-10-28 | |
US29809210P | 2010-01-25 | 2010-01-25 | |
US30581910P | 2010-02-18 | 2010-02-18 | |
PCT/US2010/028906 WO2010111644A1 (en) | 2009-03-26 | 2010-03-26 | Pharmaceutical formulations and methods for treating respiratory tract infections |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE538774T1 true ATE538774T1 (de) | 2012-01-15 |
Family
ID=42562904
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT10711127T ATE538774T1 (de) | 2009-03-26 | 2010-03-26 | Pharmazeutische formulierungen und verfahren zur behandlung von atemwegsinfektionen |
Country Status (20)
Country | Link |
---|---|
US (2) | US20120107414A1 (de) |
EP (1) | EP2315580B1 (de) |
JP (1) | JP2012522011A (de) |
KR (1) | KR20120002981A (de) |
CN (1) | CN102448440A (de) |
AT (1) | ATE538774T1 (de) |
AU (1) | AU2010229724B2 (de) |
BR (1) | BRPI1014783A2 (de) |
CA (1) | CA2754680A1 (de) |
DK (1) | DK2315580T3 (de) |
ES (1) | ES2379775T3 (de) |
HK (1) | HK1156847A1 (de) |
HR (1) | HRP20120262T1 (de) |
IL (1) | IL215275A0 (de) |
MX (1) | MX2011009959A (de) |
PL (1) | PL2315580T3 (de) |
PT (1) | PT2315580E (de) |
RS (1) | RS52239B (de) |
RU (1) | RU2011137961A (de) |
WO (1) | WO2010111644A1 (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2702094C (en) | 2007-10-10 | 2018-05-01 | Parion Sciences, Inc. | Delivering osmolytes by nasal cannula |
AU2010229730A1 (en) * | 2009-03-26 | 2011-10-06 | Pulmatrix, Inc. | Calcium citrate and calcium lactate formulations for alteration of biophysical properties of mucosal lining |
ES2625260T5 (es) | 2009-03-26 | 2020-07-29 | Pulmatrix Operating Co Inc | Formulaciones de polvo seco y métodos para el tratamiento de enfermedades pulmonares |
CN103200938B (zh) | 2010-08-30 | 2018-07-31 | 普马特里克斯营业公司 | 干燥粉末配方及用于治疗肺部疾病的方法 |
EP2448571B1 (de) | 2010-08-30 | 2013-06-12 | Pulmatrix, Inc. | Einatembares trockenpulver mit calciumlactat, natriumchlorid und leukin |
CA2812414C (en) | 2010-09-29 | 2020-09-22 | Pulmatrix, Inc. | Monovalent metal cation dry powders for inhalation |
ES2899621T3 (es) | 2010-09-29 | 2022-03-14 | Pulmatrix Operating Co Inc | Polvos secos catiónicos que comprenden sal de magnesio |
EP2717855A4 (de) * | 2011-06-07 | 2014-11-12 | Parion Sciences Inc | Behandlungsverfahren |
US8945605B2 (en) | 2011-06-07 | 2015-02-03 | Parion Sciences, Inc. | Aerosol delivery systems, compositions and methods |
US20140336159A1 (en) | 2011-10-07 | 2014-11-13 | Pulmatrix, Inc. | Methods for treating and diagnosing respiratory tract infections |
JP2015509788A (ja) | 2012-02-29 | 2015-04-02 | パルマトリックス,インコーポレイテッド | 吸入に適した乾燥粉末 |
US9636360B2 (en) * | 2012-09-18 | 2017-05-02 | pH Science Holdings, Inc | Method and composition for treating gastro-esophageal disorders |
JP6473738B2 (ja) | 2013-04-01 | 2019-02-20 | パルマトリックス,インコーポレイテッド | チオトロピウム乾燥粉末 |
KR101658048B1 (ko) * | 2014-06-25 | 2016-09-20 | 한국생명공학연구원 | 포스파티딜콜린 합성경로 관여 물질을 포함하는 항바이러스용 조성물 |
DK3212212T3 (da) | 2014-10-31 | 2020-12-21 | Univ Monash | Pulverformulering |
US10046007B2 (en) | 2015-06-24 | 2018-08-14 | Prescient Pharma, Llc | Compositions and methods for treatment of short telomere disorders |
US11141545B2 (en) * | 2016-12-01 | 2021-10-12 | Mark L. Anderson, Llc | Sprayer technology |
FR3081325B1 (fr) * | 2018-05-23 | 2020-10-09 | Univ Claude Bernard Lyon | Diltiazem pour son utilisation dans le traitement des infections microbiennes |
US12018082B2 (en) * | 2019-09-16 | 2024-06-25 | The Regents Of The University Of California | Methods and agents for treating infections |
IT202000005026A1 (it) * | 2020-03-09 | 2021-09-09 | Sofar Spa | Lattoferrina per uso inalatorio ad azione antivirale |
WO2021245656A1 (en) * | 2020-05-31 | 2021-12-09 | Nicogen Ltd. | Nicotine compositions for inhalation and anti-viral uses thereof |
CN113827614A (zh) * | 2020-06-24 | 2021-12-24 | 厦门大学 | 制备药用混合物的方法、所得药用混合物及其医药用途 |
EP4192472A1 (de) * | 2020-08-10 | 2023-06-14 | Reverspah LLC | Verfahren und zusammensetzung zur behandlung von coronavirus, influenza und akutem atemnotsyndrom |
CN111759851B (zh) * | 2020-08-17 | 2021-01-26 | 广东盛普生命科技有限公司 | 单宁酸在制备抗冠状病毒的药物方面的应用 |
WO2022187702A1 (en) * | 2021-03-05 | 2022-09-09 | Philera New Zealand | Prevention and treatment of coronavirus and related respiratory infections |
CN114410745B (zh) * | 2022-02-16 | 2023-05-02 | 长沙索科亚生物技术有限公司 | 粘性生物样本液化剂及其组合产品、试剂盒、扩增方法、检测方法和应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4637815A (en) * | 1985-08-06 | 1987-01-20 | Lemole Gerald M | Irrigational hemostatic solution |
JPH085779B2 (ja) * | 1989-09-22 | 1996-01-24 | 杏林製薬株式会社 | フレロキサシン点眼液 |
US5466680A (en) * | 1992-03-26 | 1995-11-14 | Cytologics, Inc. | Method and compositions for enhancing white blood cell functioning on a mucosal or cutaneous surface |
JP3414539B2 (ja) * | 1994-05-11 | 2003-06-09 | 有限会社ドット | 経鼻吸収用組成物 |
SK284948B6 (sk) * | 2000-04-06 | 2006-03-02 | Zentiva, A. S. | Liečivý prípravok s obsahom vápnika alebo zmesi vápnika a vitamínu D, alebo zmesi vápnika a horčíka v novej liekovej forme |
CN1194062C (zh) * | 2003-04-04 | 2005-03-23 | 王泽斌 | 一种融雪融冰组合物及其制备方法和应用 |
US20050207983A1 (en) * | 2004-03-05 | 2005-09-22 | Pulmatrix, Inc. | Formulations decreasing particle exhalation |
US20050281740A1 (en) * | 2004-06-16 | 2005-12-22 | Glen Gong | Imaging damaged lung tissue |
US20060073173A1 (en) * | 2004-10-04 | 2006-04-06 | Maria Banach | Large-scale manufacturing process for the production of pharmaceutical compositions |
NZ593475A (en) * | 2005-05-18 | 2012-12-21 | Pulmatrix Inc | Calcium salts for reducing exhalation of infectious bioaerosol particles |
AU2010229730A1 (en) * | 2009-03-26 | 2011-10-06 | Pulmatrix, Inc. | Calcium citrate and calcium lactate formulations for alteration of biophysical properties of mucosal lining |
US20120058198A1 (en) * | 2009-03-26 | 2012-03-08 | Pulmatrix, Inc. | Methods for treating and preventing pneumonia and ventilator-associated tracheobronchitis |
-
2010
- 2010-03-26 RS RS20120116A patent/RS52239B/en unknown
- 2010-03-26 CN CN2010800232634A patent/CN102448440A/zh active Pending
- 2010-03-26 BR BRPI1014783A patent/BRPI1014783A2/pt not_active IP Right Cessation
- 2010-03-26 KR KR1020117022477A patent/KR20120002981A/ko unknown
- 2010-03-26 DK DK10711127.0T patent/DK2315580T3/da active
- 2010-03-26 CA CA2754680A patent/CA2754680A1/en not_active Abandoned
- 2010-03-26 AT AT10711127T patent/ATE538774T1/de active
- 2010-03-26 WO PCT/US2010/028906 patent/WO2010111644A1/en active Application Filing
- 2010-03-26 EP EP10711127A patent/EP2315580B1/de active Active
- 2010-03-26 AU AU2010229724A patent/AU2010229724B2/en active Active
- 2010-03-26 PL PL10711127T patent/PL2315580T3/pl unknown
- 2010-03-26 JP JP2012502304A patent/JP2012522011A/ja active Pending
- 2010-03-26 RU RU2011137961/15A patent/RU2011137961A/ru unknown
- 2010-03-26 ES ES10711127T patent/ES2379775T3/es active Active
- 2010-03-26 PT PT10711127T patent/PT2315580E/pt unknown
- 2010-03-26 US US13/259,651 patent/US20120107414A1/en not_active Abandoned
- 2010-03-26 MX MX2011009959A patent/MX2011009959A/es active IP Right Grant
-
2011
- 2011-09-21 IL IL215275A patent/IL215275A0/en unknown
- 2011-10-18 HK HK11111136.9A patent/HK1156847A1/xx unknown
-
2012
- 2012-03-22 HR HR20120262T patent/HRP20120262T1/hr unknown
-
2013
- 2013-10-23 US US14/061,006 patent/US20140134251A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2010229724A1 (en) | 2011-10-06 |
EP2315580B1 (de) | 2011-12-28 |
CN102448440A (zh) | 2012-05-09 |
ES2379775T3 (es) | 2012-05-03 |
PT2315580E (pt) | 2012-03-28 |
PL2315580T3 (pl) | 2012-05-31 |
MX2011009959A (es) | 2012-01-27 |
JP2012522011A (ja) | 2012-09-20 |
RU2011137961A (ru) | 2013-05-10 |
EP2315580A1 (de) | 2011-05-04 |
AU2010229724B2 (en) | 2014-07-17 |
HRP20120262T1 (hr) | 2012-04-30 |
IL215275A0 (en) | 2011-11-30 |
RS52239B (en) | 2012-10-31 |
HK1156847A1 (en) | 2012-06-22 |
WO2010111644A1 (en) | 2010-09-30 |
US20140134251A1 (en) | 2014-05-15 |
KR20120002981A (ko) | 2012-01-09 |
CA2754680A1 (en) | 2010-09-30 |
US20120107414A1 (en) | 2012-05-03 |
BRPI1014783A2 (pt) | 2018-06-12 |
DK2315580T3 (da) | 2012-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE538774T1 (de) | Pharmazeutische formulierungen und verfahren zur behandlung von atemwegsinfektionen | |
CY1118059T1 (el) | Συνθεσεις αντιλοιμωδων βασει λιπιδιων για αγωγη πνευμονικων λοιμωξεων | |
CY1119140T1 (el) | Συνθεσεις αντικωδικευσης και μεθοδοι κατασκευης και χρησης τους | |
NZ609719A (en) | Pharmaceutical composition | |
BR112015019720A2 (pt) | inibidores de (benzil-ciano-metil)-amidas de ácido 2-aza-biciclo[2.2.1]heptano-3-carboxílico substituído da catepsina c | |
BRPI0507966A (pt) | uso de meloxicam para o tratamento de doenças respiratórias em porcos | |
EA200701519A1 (ru) | Живая аттенуированная ротавирусная вакцина для перорального введения | |
EA201100613A1 (ru) | Конденсированные, спироциклические гетероароматические соединения для лечения бактериальных инфекций | |
BR112015014458A2 (pt) | derivados de manose para o tratamento de infecções bacterianas | |
DE602005021770D1 (de) | Indol-1-yl-essigsäurederivate | |
NO20076219L (no) | Farmasoytisk formulering med apomorfin for bukkal administrering | |
EA200801580A1 (ru) | Новые производные пирониндола и способ их получения | |
EA201490653A1 (ru) | Производные эстра-1,3,5(10),16-тетраен-3-карбоксамида, способ их получения, содержащие их фармацевтические препараты, а также их применение для получения лекарственных средств | |
EA202191239A1 (ru) | Соединения и их применение для лечения дефицита 1-антитрипсина | |
ATE462438T1 (de) | Verwendung von carrageenan zur behandlung von rhinovirus-infektionen | |
CY1115961T1 (el) | Ανυδρη μορφη κρυσταλλικης μηλεϊνικης ορβεπιταντης (orvepitant maleate) | |
EA200900095A1 (ru) | Лекарственные формы бифосфонатов для ингаляции и способы их применения | |
NO20076405L (no) | Anvendelse av 24-nor-UDCA | |
MX2009006325A (es) | Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales. | |
TR201004464A2 (tr) | Kemik erimesi için formülasyon. | |
HK1131988A1 (en) | Polycyclic agents for the treatment of respiratory syncytial virus infections | |
BR112014002885A2 (pt) | uso de composto orgânico para o tratamento da síndrome de noonan | |
MX2009011818A (es) | Formulaciones de aminoacido n-halogenado con compuestos anti-inflamatorios. | |
EA201390345A1 (ru) | Терапевтическое болеутоляющее средство | |
ATE503476T1 (de) | Zusammensetzungen und verfahren zur behandlung von krankheiten, die durch infektion mit yersinia spp ausgelöst sind |